Genz-112638
Showing 1 - 13 of 13
Gaucher's Disease Type I Trial (Genz-112638, [14C]-Genz-112638)
Completed
- Gaucher's Disease Type I
- Genz-112638
- [14C]-Genz-112638
- (no location specified)
Nov 16, 2023
Gaucher Disease, Type 1 Trial in Worldwide (Eliglustat tartrate, Placebo)
Completed
- Gaucher Disease, Type 1
- Eliglustat tartrate
- Placebo
-
San Francisco, California
- +17 more
Jan 17, 2017
Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease Trial in Worldwide (Eliglustat
Completed
- Gaucher Disease, Type 1
- +4 more
- Eliglustat tartrate
-
New York, New York
- +16 more
Dec 22, 2016
Gaucher Disease Trial in Worldwide (Eliglustat tartrate)
Completed
- Gaucher Disease
- Eliglustat tartrate
-
San Diego, California
- +45 more
Dec 12, 2016
Gaucher Disease, Type 1 Trial in Worldwide (Eliglustat tartrate, Imiglucerase)
Completed
- Gaucher Disease, Type 1
- Eliglustat tartrate
- Imiglucerase
-
Beverly Hills, California
- +33 more
Oct 11, 2016
Healthy Volunteer Trial in Austin (eliglustat; digoxin, digoxin)
Completed
- Healthy Volunteer
- eliglustat; digoxin
- digoxin
-
Austin, TexasPPD Phase I Clinic
Mar 19, 2015
Healthy Volunteer Trial in Austin (Eliglustat, common blend proposed commercial formulation, Eliglustat, Phase 3 capsule
Completed
- Healthy Volunteer
- Eliglustat, common blend proposed commercial formulation
- Eliglustat, Phase 3 capsule formulation
-
Austin, TexasPPD Phase 1 Unit
Mar 19, 2015
Disease Status of Gaucher Type I Patients
Withdrawn
- Gaucher Disease, Type 1
-
New York, New York
- +2 more
May 7, 2015
Kidney Failure, Chronic Trial in Puerto Rico, United States (Placebo, Genz-644470, Sevelamer carbonate)
Completed
- Kidney Failure, Chronic
- Placebo
- +2 more
-
Alexander City, Alabama
- +52 more
Apr 15, 2015
Healthy Trial in Austin (Genz-682452, Placebo)
Completed
- Healthy
- Genz-682452
- Placebo
-
Austin, Texas(unnamed)
Mar 17, 2014
Solid Tumors Trial in United States (Genz-644282 (28-day dosing schedule), Genz-644282 (21-day dosing schedule))
Completed
- Solid Tumors
- Genz-644282 (28-day dosing schedule)
- Genz-644282 (21-day dosing schedule)
-
Scottsdale, Arizona
- +3 more
Mar 17, 2014